01 1Sun Pharmaceutical Industries Limited
01 1ATORVASTATIN CALCIUM TRIHYDRATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-06-22
Pay. Date : 2020-06-16
DMF Number : 24139
Submission : 2010-09-07
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ATORVASTATIN CALCIUM TRIHYDRATE USP, with a corresponding US DMF Number 24139.
Remarkably, this DMF maintains an Active status since its submission on September 07, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 22, 2020, and payment made on June 16, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
